Search

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year.

… Monday, December 18, 2023 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatment for patients in 2023. The results from many cutting-edge clinical trials this year are leading to promising new treatments for brain cancer, colorectal cancer, bladder

Three students have successfully defended their dissertations and will receive their PhD degrees at commencement on May 21.

… Friday, May 15, 2015 Three students at the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences have successfully defended their dissertations. As part of Memorial Sloan Kettering’s 36th annual academic convocation and the school’s fourth annual commencement on May 21, GSK will award PhD degrees

Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.

… Thursday, March 2, 2017 Summary The Sloan Kettering Institute is home to many biologists who study basic biological processes fundamental to all cells. DNA replication and repair is an area where SKI excels. John Petrini , Chair of the Molecular Biology Program at SKI, is a world expert on the mechanics

Learn about a hospital-wide program that empowers children before they undergo surgery at Memorial Sloan Kettering.

… Friday, March 16, 2018 Summary A new program at Memorial Sloan Kettering is ensuring that our youngest patients get age-appropriate care before surgery . It’s before dawn in New York City, but the day is already well under way for Maria Martin. Ms. Martin is a child-life therapist at Memorial Sloan Kettering

Nine GSK PhD students were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).

… Friday, October 4, 2024 This past academic year, nine PhD students enrolled at the  Gerstner Sloan Kettering Graduate School of Biomedical Sciences  (GSK) were awarded competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation

Learn about a noninvasive lung cancer test called "E-nose" that is being investigated at Memorial Sloan Kettering.

… Monday, July 8, 2024 Detecting  lung cancer as early as possible has long been a goal of the specialists at MSK, because it gives doctors the most treatment options, which can improve outcomes for patients.    A team led by MSK  thoracic surgeon Gaetano Rocco, MD , reported results in a clinical trial

Conozca una prueba no invasiva para el cáncer pulmonar llamada “nariz electrónica” que está siendo investigada en Memorial Sloan Kettering.

… Monday, July 8, 2024 Detectar el  cáncer pulmonar lo antes posible ha sido durante mucho tiempo un objetivo de los especialistas de MSK, ya que les brinda a los médicos más opciones de tratamiento, lo que puede mejorar los resultados para los pacientes.    Un equipo dirigido por el cirujano torácico

Learn how people with early stage breast cancer can receive radiation therapy without the need for tattoos at Memorial Sloan Kettering Cancer Center.

… Tuesday, January 3, 2023 Memorial Sloan Kettering Cancer Center offers tattoo-less radiation therapy for early-stage breast cancer. MSK’s tattoo-less radiation uses Surface Guided Radiation Therapy that is just as accurate as radiotherapy with tattoos and can be done more quickly. The experts at Memorial

New MSK research uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT® could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.

… Wednesday, December 18, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT ® could be used for

Research at Memorial Sloan Kettering Cancer Center suggests that what’s usually considered low-risk ductal carcinoma in situ (DCIS) may still present significant risk. Two European trials comparing observation to surgical excision for women with low-risk DCIS are expected to provide important additional data.

… Thursday, June 23, 2016 The DCIS Treatment Controversy The appropriate management of women with ductal carcinoma in situ (DCIS) remains an area of ongoing controversy. DCIS is a noninvasive breast lesion diagnosed in more than 60,000 patients annually in the United States, currently accounting for 20